These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 19317099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune). Study of 297 cases in Togo].
    Mouhari-Touré A, Saka B, Kombat K, Tchangaï-Walla K, Pitche P.
    Bull Soc Pathol Exot; 2008 Dec; 101(5):404-6. PubMed ID: 19192611
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
    Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E.
    AIDS; 2007 Mar 30; 21(6):768-71. PubMed ID: 17413701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
    Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E.
    Lancet; 2007 Mar 30; 364(9428):29-34. PubMed ID: 15234853
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
    van Oosterhout JJ, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, de Baar MP, Schuurman R, Burger DM, Zijlstra EE.
    Trop Med Int Health; 2005 May 30; 10(5):464-70. PubMed ID: 15860093
    [Abstract] [Full Text] [Related]

  • 8. Reflections: neurology and the humanities: reflections for October.
    Birbeck GL.
    Neurology; 2009 Oct 13; 73(15):1245-6. PubMed ID: 19822877
    [No Abstract] [Full Text] [Related]

  • 9. Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.
    Rey D, L'Héritier A, Lang JM.
    Clin Infect Dis; 2002 Feb 01; 34(3):418-9. PubMed ID: 11774091
    [No Abstract] [Full Text] [Related]

  • 10. Long-term safety and efficacy of nevirapine, stavudine and lamivudine in a real-world setting.
    Shalit P, Farrell P, Lindgren P.
    AIDS; 2001 Apr 13; 15(6):804-5. PubMed ID: 11371699
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.
    Tin EE, Bowonwatanuwong C, Desakorn V, Wilairatana P, Krudsood S, Pitisuttithum P.
    Southeast Asian J Trop Med Public Health; 2005 Mar 13; 36(2):362-9. PubMed ID: 15916042
    [Abstract] [Full Text] [Related]

  • 12. A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
    George C, Yesoda A, Jayakumar B, Lal L.
    J Clin Pharm Ther; 2009 Feb 13; 34(1):33-40. PubMed ID: 19125901
    [Abstract] [Full Text] [Related]

  • 13. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
    Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L, Médecins Sans Frontieres.
    AIDS; 2006 May 12; 20(8):1163-9. PubMed ID: 16691068
    [Abstract] [Full Text] [Related]

  • 14. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S, Antunes OA, Fortunak JM.
    Antiviral Res; 2008 Sep 12; 79(3):143-65. PubMed ID: 18571246
    [Abstract] [Full Text] [Related]

  • 15. Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
    Mulenga V, Cook A, Walker AS, Kabamba D, Chijoka C, Ferrier A, Kalengo C, Kityo C, Kankasa C, Burger D, Thomason M, Chintu C, Gibb DM.
    Clin Infect Dis; 2010 Nov 01; 51(9):1081-9. PubMed ID: 20868279
    [Abstract] [Full Text] [Related]

  • 16. Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report.
    Pensi T.
    Indian Pediatr; 2007 Jul 01; 44(7):519-21. PubMed ID: 17684304
    [Abstract] [Full Text] [Related]

  • 17. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
    Kyaw NL, Thanachartwet V, Kiertiburanakul S, Desakorn V, Chamnanchanunt S, Chierakul W, Manosuthi W, Pitisuttithum P, Sungkanuparph S.
    Southeast Asian J Trop Med Public Health; 2013 Mar 01; 44(2):232-43. PubMed ID: 23691633
    [Abstract] [Full Text] [Related]

  • 18. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE.
    Antivir Ther; 2007 Mar 01; 12(4):515-21. PubMed ID: 17668560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.